Clinical and Experimental Pediatrics

The Korean Pediatric Society (대한소아청소년과학회)
권호 표지
DOI QR코드

DOI QR Code

Detection rate and clinical impact of respiratory viruses in children with Kawasaki disease

  • Kim, Ja Hye (Department of Pediatrics, University of Ulsan College of Medicine) ;
  • Yu, Jeong Jin (Department of Pediatrics, University of Ulsan College of Medicine) ;
  • Lee, Jina (Department of Pediatrics, University of Ulsan College of Medicine) ;
  • Kim, Mi-Na (Department of Laboratory Medicine, University of Ulsan College of Medicine) ;
  • Ko, Hong Ki (Department of Pediatrics, University of Ulsan College of Medicine) ;
  • Choi, Hyung Soon (Department of Pediatrics, Kosin University Gospel Hospital) ;
  • Kim, Young-Hwue (Department of Pediatrics, University of Ulsan College of Medicine) ;
  • Ko, Jae-Kon (Department of Pediatrics, University of Ulsan College of Medicine)
  • Received : 2012.08.03
  • Accepted : 2012.10.22
  • Published : 2012.12.15
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: The purpose of this prospective case-control study was to survey the detection rate of respiratory viruses in children with Kawasaki disease (KD) by using multiplex reverse transcriptase-polymerase chain reaction (RT-PCR), and to investigate the clinical implications of the prevalence of respiratory viruses during the acute phase of KD. Methods: RT-PCR assays were carried out to screen for the presence of respiratory syncytial virus A and B, adenovirus, rhinovirus, parainfluenza viruses 1 to 4, influenza virus A and B, metapneumovirus, bocavirus, coronavirus OC43/229E and NL63, and enterovirus in nasopharyngeal secretions of 55 KD patients and 78 control subjects. Results: Virus detection rates in KD patients and control subjects were 32.7% and 30.8%, respectively (P=0.811). However, there was no significant association between the presence of any of the 15 viruses and the incidence of KD. Comparisons between the 18 patients with positive RT-PCR results and the other 37 KD patients revealed no significant differences in terms of clinical findings (including the prevalence of incomplete presentation of the disease) and coronary artery diameter. Conclusion: A positive RT-PCR for currently epidemic respiratory viruses should not be used as an evidence against the diagnosis of KD. These viruses were not associated with the incomplete presentation of KD and coronary artery dilatation.

Keywords

References

  1. Bell DM, Brink EW, Nitzkin JL, Hall CB, Wulff H, Berkowitz ID, et al. Kawasaki syndrome: description of two outbreaks in the United States. N Engl J Med 1981;304:1568-75. https://doi.org/10.1056/NEJM198106253042603
  2. Treadwell TA, Maddox RA, Holman RC, Belay ED, Shahriari A, Anderson MS, et al. Investigation of Kawasaki syndrome risk factors in Colorado. Pediatr Infect Dis J 2002;21:976-8. https://doi.org/10.1097/00006454-200210000-00018
  3. Raymond F, Carbonneau J, Boucher N, Robitaille L, Boisvert S, Wu WK, et al. Comparison of automated microarray detection with realtime PCR assays for detection of respiratory viruses in specimens obtained from children. J Clin Microbiol 2009;47:743-50. https://doi.org/10.1128/JCM.01297-08
  4. Cho EY, Eun BW, Kim NH, Lee J, Choi EH, Lee HJ, et al. Association between Kawasaki disease and acute respiratory viral infections. Korean J Pediatr 2009;52:1241-8. https://doi.org/10.3345/kjp.2009.52.11.1241
  5. Jordan-Villegas A, Chang ML, Ramilo O, Mejias A. Concomitant respiratory viral infections in children with Kawasaki disease. Pediatr Infect Dis J 2010;29:770-2. https://doi.org/10.1097/INF.0b013e3181dba70b
  6. Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Pediatrics 2004;114:1708-33. https://doi.org/10.1542/peds.2004-2182
  7. Japan Kawasaki Disease Research Committee. Report of subcommittee on standardization of diagnostic criteria and reporting of coronary artery lesions in Kawasaki disease. Tokyo: Ministry of Health and Welfare, 1984.
  8. Korea Centers for Disease Control and Prevention. Acute infectious agents laboratory surveillance reports [Internet]. Cheongwon: Korea Centers for Disease Control and Prevention; c2012 [2012 Feb 1]. Available from: http://www.cdc.go.kr.
  9. Yu JJ, Cho SK, Park YM, Lee R, Chung S, Bae SH. Coronary artery diameter of normal children aged 3 months to 6 years. Korean J Pediatr 2008;51:629-33. https://doi.org/10.3345/kjp.2008.51.6.629
  10. Kawasaki T. Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children. Arerugi 1967;16:178-222.
  11. Rowley AH. Finding the cause of Kawasaki disease: a pediatric infectious diseases research priority. J Infect Dis 2006;194:1635-7. https://doi.org/10.1086/509514
  12. Rowley AH, Baker SC, Shulman ST, Fox LM, Takahashi K, Garcia FL, et al. Cytoplasmic inclusion bodies are detected by synthetic antibody in ciliated bronchial epithelium during acute Kawasaki disease. J Infect Dis 2005;192:1757-66. https://doi.org/10.1086/497171
  13. Rowley AH, Baker SC, Shulman ST, Rand KH, Tretiakova MS, Perlman EJ, et al. Ultrastructural, immunofluorescence, and RNA evidence support the hypothesis of a "new" virus associated with Kawasaki disease. J Infect Dis 2011;203:1021-30. https://doi.org/10.1093/infdis/jiq136
  14. Lehmann C, Klar R, Lindner J, Lindner P, Wolf H, Gerling S. Kawasaki disease lacks association with human coronavirus NL63 and human bocavirus. Pediatr Infect Dis J 2009;28:553-4. https://doi.org/10.1097/INF.0b013e31819f41b6

Cited by

  1. Viral infections associated with Kawasaki disease vol.113, pp.3, 2012, https://doi.org/10.1016/j.jfma.2013.12.008
  2. Evaluation of the Temporal Association between Kawasaki Disease and Viral Infections in South Korea vol.44, pp.4, 2012, https://doi.org/10.4070/kcj.2014.44.4.250
  3. Cardiac Function in Kawasaki Disease Patients with Respiratory Symptoms vol.45, pp.4, 2012, https://doi.org/10.4070/kcj.2015.45.4.317
  4. Concurrent Respiratory Viruses and Kawasaki Disease vol.136, pp.3, 2012, https://doi.org/10.1542/peds.2015-0950
  5. Use of corticosteroids during acute phase of Kawasaki disease vol.4, pp.4, 2015, https://doi.org/10.5409/wjcp.v4.i4.135
  6. Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association vol.135, pp.17, 2012, https://doi.org/10.1161/cir.0000000000000484
  7. Comparison of Clinical Manifestation and Laboratory Findings between Adenoviral Infection with or without Kawasaki Disease vol.41, pp.3, 2012, https://doi.org/10.12771/emj.2018.41.3.45
  8. Discrimination of Kawasaki disease with concomitant adenoviral detection differentiating from isolated adenoviral infection vol.61, pp.2, 2012, https://doi.org/10.3345/kjp.2018.61.2.43
  9. Profile of resistance to IVIG treatment in patients with Kawasaki disease and concomitant infection vol.13, pp.10, 2012, https://doi.org/10.1371/journal.pone.0206001
  10. A novel variant of torque teno virus 7 identified in patients with Kawasaki disease vol.13, pp.12, 2018, https://doi.org/10.1371/journal.pone.0209683
  11. Kawasaki-like multisystem inflammatory syndrome in children during the covid-19 pandemic in Paris, France: prospective observational study vol.369, pp.None, 2020, https://doi.org/10.1136/bmj.m2094
  12. COVID19: potential cardiovascular issues in pediatric patients vol.91, pp.2, 2012, https://doi.org/10.23750/abm.v91i2.9655
  13. COVID 19 and immune phenomenon in children vol.11, pp.2, 2012, https://doi.org/10.4103/injms.injms_59_20
  14. COVID-19 and Kawasaki Disease: Novel Virus and Novel Case vol.10, pp.6, 2020, https://doi.org/10.1542/hpeds.2020-0123
  15. COVID-19 and Autoimmune Diseases: A Systematic Review of Reported Cases vol.16, pp.None, 2012, https://doi.org/10.2174/1573397116666201029155856
  16. Acute Cardiovascular Manifestations in 286 Children With Multisystem Inflammatory Syndrome Associated With COVID-19 Infection in Europe vol.143, pp.1, 2012, https://doi.org/10.1161/circulationaha.120.050065
  17. A meta-analysis on association between viral infections and Kawasaki disease in children vol.16, pp.1, 2012, https://doi.org/10.2217/fvl-2020-0212
  18. COVID-19-Related Giant Coronary Aneurysms in an Infant with Multisystem Inflammatory Disorder in Children: The First Case Report from the United Arab Emirates and the Arab Region vol.2021, pp.None, 2012, https://doi.org/10.1155/2021/8872412
  19. Kawasaki disease presenting with hoarseness: A multinational study of the REKAMLATINA network vol.63, pp.6, 2021, https://doi.org/10.1111/ped.14521
  20. Kawasaki disease and influenza-new lessons from old associations vol.40, pp.7, 2012, https://doi.org/10.1007/s10067-020-05534-1
  21. Seasonal Trends of Viral Prevalence and Incidence of Kawasaki Disease: A Korea Public Health Data Analysis vol.10, pp.15, 2021, https://doi.org/10.3390/jcm10153301